eprintid: 34681
rev_number: 8
eprint_status: archive
userid: 4229
dir: disk0/00/03/46/81
datestamp: 2024-06-12 08:01:12
lastmod: 2024-06-12 08:01:12
status_changed: 2024-06-12 08:01:12
type: article
metadata_visibility: show
creators_name: Ujianti, Irena
creators_name: lakshmi, bety semara
creators_name: Nurusshofa, Zahra
creators_name: sukarya, wawang s
creators_id: irenaujianti@uhamka.ac.id
creators_id: bety_semara@uhamka.ac.id
creators_id: zahra.nurusshofa@uhamka.ac.id
creators_id: wawangsetiawansukarya@gmail.com
creators_orcid: 0000-0003-2475-431X
creators_orcid: 0000-0002-8819-9370
title: Evaluation of the potential of Stichopus Herrmanni extract in inhibiting cervical cancer cell proliferation
ispublished: pub
subjects: R1
divisions: 11201
abstract: Background: Sea cucumbers, particularly Stichopus herrmanni, are known for their medicinal value in Asian
traditional medicine owing to the abundant presence of saponins, terpenoids, and phenols. Investigations on
these bioactive compounds have revealed their cytotoxic propensity against various cancer cell lines, indicating

their therapeutic potential. However, limited research exists on the potential application of sea cucumber ex-
tracts specifically in cervical cancer.

Purpose: This study aimed to identify the bioactive components of Stichopus herrmanni extract, determine their
association with potential targets in cervical cancer, and evaluate their cytotoxic effects on cervical cancer cells.
Study Design: This experimental study employed both in vitro and in silico methods to evaluate the potential
cytotoxic effects of Stichopus herrmanni extracts on cervical cancer cells.
Methods: Liquid Chromatography-Mass Spectrometry (LC-MS) was used to identify and quantify the bioactive

constituents of Stichopus herrmanni crude extract. An in silico approach was used to identify the active compo-
nents, potential targets, and signaling pathways of the extract. Furthermore, the MTT assay was used to deter-
mine the cytotoxicity of the extract.

Results: LC-MS analysis identified the presence of rengyol, eucommiol, ganoderic acid, and 6-isoinosine in the
extracts. An in silico study based on structural analysis identified ganoderic acid and isoinosine as crucial active
components capable of regulating majority of the targets associated with cervical cancer. Overlapping targets,
namely, CASP3, CAT, FASLG, IL24, TP53, TP53BP1, ALB, BDNF, and COX2 between cervical cancer and the
extract highlighted new therapeutic prospects for cervical cancer following protein-protein interaction network
screening. The in vitro cytotoxic effects of the extracts were established in HeLa cells.
Conclusion: Research indicates that Stichopus herrmanni may be a valuable source of bioactive compounds with
potential applications in the treatment of cancer and the induction of apoptosis
date: 2024-08
date_type: published
publisher: Elsevier
full_text_status: public
publication: Phytomedicine Plus
volume: 4
number: 100557
refereed: TRUE
issn: 2667-0313
related_url_url: https://www.sciencedirect.com/science/article/pii/S2667031324000526
funders: lemlit Uhamka
citation:   Ujianti, Irena dan lakshmi, bety semara dan Nurusshofa, Zahra dan sukarya, wawang s  (2024) Evaluation of the potential of Stichopus Herrmanni extract in inhibiting cervical cancer cell proliferation.  Phytomedicine Plus, 4 (100557).   ISSN 2667-0313     
document_url: http://repository.uhamka.ac.id/id/eprint/34681/1/ScopusQ2_elsevier_sticopus%20and%20cervical%20cancer.pdf